We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
66 hedge funds and large institutions have $290M invested in Evelo Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
510% more call options, than puts
Call options by funds: $2.54M | Put options by funds: $417K
190% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 10
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
3% more funds holding
Funds holding: 64 → 66 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less capital invested
Capital invested by funds: $332M → $290M (-$41.6M)
Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
29
Reduced
10
Closed
9
Calls
$2.54M
Puts
$417K
Net Calls
+$2.13M
Net Calls Change
+$3.79M
Top Buyers
| 1 |
BlackRock
New York
|
+$2.25M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.16M |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$1.07M |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
+$873K |
| 5 |
Millennium Management
New York
|
+$755K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$710K |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$309K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$273K |
| 4 |
Two Sigma Advisers
New York
|
-$254K |
| 5 |
Morgan Stanley
New York
|
-$251K |
